ArticleActa pharmaceutica Sinica. B2025

USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells.

Yang Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.